Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
Augmedix (Nasdaq: AUGX) will announce its first quarter 2024 financial results on May 13, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Augmedix (Nasdaq: AUGX) will announce its first quarter 2024 financial results on May 13, 2024. The company specializes in ambient AI medical documentation and data solutions. Management will host a conference call the same day at 1:30 p.m. PT / 4:30 p.m. ET.
Details
News Market Reaction – AUGX
The recorded move for AUGX in the trading session of this news was -4.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET.
- Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)
- Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1666696&tp_key=f217dd82fa
An archived replay will be available following the call on Augmedix’s IR website at https://ir.augmedix.com/.
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust.
The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support.
Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.